Recently Released Market Study: South Korea Pharmaceuticals & Healthcare Report Q1 2013
BMI View: Given the commitment to innovation in both the public and the private sector in the country, South Korea will continue to be one of the key leaders in research and development (R&D) in the Asia Pacific region. However, we continue to see challenges to multinational companies posed by the toughness of the country's drug pricing environment. Nevertheless, manufacturers will continue to benefit from relatively high per capita spending on medicines and the steady volume demand driven by trends...
View full press release